Thomas Monath And Russell Middaugh Join Scientific Advisory Board Of VAXESS Technologies

Innovative vaccine stabilization company adds experts with extensive experience in vaccine development and formulation April 4, 2014 Vaxess Technologies, Inc., an innovative life sciences company developing a novel vaccine stabilization technology, announced today the addition of two new members to the company‚Äôs scientific advisory board: Thomas Monath, MD, and Russell Middaugh, PhD. Dr. Monath and Dr. Middaugh will be instrumental …